{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T20:14:15Z","timestamp":1648930455634},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1451,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ijid.2008.11.018","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T16:57:10Z","timestamp":1235494630000},"page":"e331-e332","source":"Crossref","is-referenced-by-count":3,"title":["A role for carbapenem in the treatment of melioidosis in developing countries?"],"prefix":"10.1016","volume":"13","author":[{"given":"Panthipa","family":"Laowansiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundeep","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pattarachai","family":"Kiratisin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anucha","family":"Apisarnthanarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2008.11.018_bib1","unstructured":"Clinical and Laboratory Standards Institute (CLSI), 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. CLSI, Pennsylvania, USA."},{"key":"10.1016\/j.ijid.2008.11.018_bib2","unstructured":"Paveenkittiporn W, Apisarnthanarak A, Trakoolsomboon S, Dejsirilert S. Five years surveillance for Burkholderia pseudomallei in Thailand, 2000\u20132004: prevalence, clinical epidemiology and antimicrobial susceptibility. J Med Assoc Thai 2009 (In press)."},{"key":"10.1016\/j.ijid.2008.11.018_bib3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/clinids\/19.5.846","article-title":"Ceftazidime vs. amoxicillin\/clavulanate in the treatment of severe melioidosis","volume":"19","author":"Suputtamongkol","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2008.11.018_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/520219","article-title":"Comparison of imipenem and ceftazidime as therapy for severe melioidosis","volume":"29","author":"Simpson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2008.11.018_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/320878","article-title":"Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis","volume":"33","author":"Chetchotisakd","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2008.11.018_bib6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/315306","article-title":"Differential antibiotic-induced endotoxin release in severe melioidosis","volume":"181","author":"Simpson","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2008.11.018_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/33.1.145","article-title":"Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies","volume":"33","author":"Smith","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2008.11.018_bib8","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.39.10.2356","article-title":"Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment","volume":"39","author":"Walsh","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2008.11.018_bib9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/444456","article-title":"Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis","volume":"41","author":"Chierakul","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2008.11.018_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/380456","article-title":"Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis","volume":"38","author":"Cheng","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971209000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971209000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T12:54:49Z","timestamp":1545396889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971209000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1201971209000162"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2008.11.018","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}